|Podcasts|February 22, 2022
Clinical Trials Separate the Signal from the Noise
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Avi Kulkarni, Senior Vice President, Research & Development, at Cognizant, discusses the trajectory and growth of the Shared Investigator Platform; the history and impact of biomarkers in clinical trial conducts, as well as personal insights from his 30-year career.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
2
Operational Pragmatism in ePRO-heavy trials
3
How Selective Safety Data Collection Could Make Pragmatic Trials Scalable
4